• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

TCR engineered T-cells

	Next higher product group	cancer immunotherapy (immuno-oncology, I-O)

Record changed: 2021-02-10

Advertisement

More documents for TCR engineered T-cells

• [1] Pan Cancer T B.V.. (2/8/21). "Press Release: Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center"....
• [2] Medigene AG. (1/28/21). "Press Release: Focus on Solid Tumors – Discontinuation of MDG1021 Development Program". Planegg-Martinsried....
• [3] TScan Therapeutics Inc.. (1/25/21). "Press Release: TScan Therapeutics Announces $100 Million Series C Financing". Waltham, MA....
• [4] Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY....
• [5] Immatics N.V.. (9/29/20). "Press Release: Immatics Appoints Arnd Christ as Chief Financial Officer". Tübingen & Houston, TX....
• [6] Neogene Therapeutics, Inc.. (9/14/20). "Press Release: Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies". New York, NY & Amsterdam....
• [7] Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried....
• [8] Immatics Biotechnologies GmbH. (2/20/20). "Press Release: Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies". Tübingen & Houston, TX....
• [9] Ervaxx Ltd.. (1/24/20). "Press Release: Ervaxx and Cardiff University Enter Collaboration to Develop novel T-cell and T-cell Receptor-based Immunotherapeutics Targeting Dark Antigens". London....
• [10] Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.